SUPERSTRING CAPITAL MANAGEMENT LP
Top Portfolio Positions
35 positions ·
$139,969,950 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
892,873 | $16,928,872 | 12.09% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
357,606 | $8,882,933 | 6.35% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
225,158 | $8,666,331 | 6.19% | |
| SVRA |
Savara Inc
Healthcare
|
1,585,977 | $8,659,434 | 6.19% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
387,371 | $6,964,930 | 4.98% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
351,461 | $6,642,612 | 4.75% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
730,548 | $6,545,710 | 4.68% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
110,454 | $6,418,481 | 4.59% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
180,048 | $5,711,122 | 4.08% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
141,024 | $5,653,652 | 4.04% |
Portfolio Trend
10 quarters · across all stocks
Holdings in URGN
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,964,930 | 387,371 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,823,850 | 718,354 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,753,844 | 87,912 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,204,394 | 87,912 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,685,369 | 423,632 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,207,843 | 301,206 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $4,324,005 | 288,267 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,831,450 | 255,430 | Shares | Sole | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||